Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma | Zendy

Miyuki Taniguchi | Zendy; Soo Ryang Kim | Zendy; Susumu Imoto | Zendy; Hirotsugu Ikawa | Zendy; Kenji Ando | Zendy; Keiji Mita | Zendy; Shuichi Fuki | Zendy; Noriko Sasase | Zendy; Toshiyuki Matsuoka | Zendy; Masatoshi Kudo | Zendy; Yoshitake Hayashi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma

Author(s) -

Miyuki Taniguchi,

Soo Ryang Kim,

Susumu Imoto,

Hirotsugu Ikawa,

Kenji Ando,

Keiji Mita,

Shuichi Fuki,

Noriko Sasase,

Toshiyuki Matsuoka,

Masatoshi Kudo,

Yoshitake Hayashi

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.1997

Subject(s) - hepatocellular carcinoma , percutaneous ethanol injection , medicine , gastroenterology , liver function , percutaneous , radiofrequency ablation , survival rate , hepatitis b virus , hepatitis c virus , hepatitis b , surgery , virus , ablation , immunology

To evaluate long-term follow-up of minimum-sized hepatocellular carcinoma (HCC) treated with percutaneous ethanol injection (PEI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research